Notably, numerous clinical studies have demonstrated a strong association between complement levels and disease activity in autoimmune disorders [14,36,37], suggesting that CD8+ T cells may serve as potential biomarkers for predicting disease activity in Sjögren’s syndrome. This evidence concerns the gene CD8A and Sjogren syndrome.